よむ、つかう、まなぶ。
08参考資料１ ヒトパピローマウイルス（HPV）ワクチンファクトシート追補版 (63 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_63875.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第31回 9／25）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
参考文献
1.
Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution
in anal cancer and anal intraepithelial lesions. Int J Cancer. 2009;124(10):2375-83.
2.
Deshmukh AA, Suk R, Shiels MS, Sonawane K, Nyitray AG, Liu Y, et al. Recent Trends
in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001-2015.
J Natl Cancer Inst. 2020;112(8):829-38.
3.
Palefsky JM, Giuliano AR, Goldstone S, Moreira ED, Jr., Aranda C, Jessen H, et al.
HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med.
2011;365(17):1576-85.
4.
Bruyere D, Monnien F, Colpart P, Roncarati P, Vuitton L, Hendrick E, et al. Treatment
algorithm and prognostic factors for patients with stage I-III carcinoma of the anal canal: a 20-year
multicenter study. Mod Pathol. 2021;34(1):116-30.
5.
McBride AA, Warburton A. The role of integration in oncogenic progression of HPV-
associated cancers. PLoS Pathog. 2017;13(4):e1006211.
6.
Salati SA, Al Kadi A. Anal cancer - a review. Int J Health Sci (Qassim). 2012;6(2):206-
30.
7.
Gervaz P, Hirschel B, Morel P. Molecular biology of squamous cell carcinoma of the anus.
Br J Surg. 2006;93(5):531-8.
8.
D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control
study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944-56.
9.
Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human
papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):2435.
10.
Hama T, Tokumaru Y, Fujii M, Yane K, Okami K, Kato K, et al. Prevalence of human
papillomavirus in oropharyngeal cancer: a multicenter study in Japan. Oncology. 2014;87(3):17382.
11.
Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for
a causal association between human papillomavirus and a subset of head and neck cancers. J Natl
Cancer Inst. 2000;92(9):709-20.
12.
Nguyen NP, Chi A, Nguyen LM, Ly BH, Karlsson U, Vinh-Hung V. Human
papillomavirus-associated oropharyngeal cancer: a new clinical entity. Qjm. 2010;103(4):229-36.
13.
Klussmann JP, Mooren JJ, Lehnen M, Claessen SM, Stenner M, Huebbers CU, et al.
Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic
implications. Clin Cancer Res. 2009;15(5):1779-86.
14.
Network
NCC.
NCCN
Guidelines
https://www.nccn.org/guidelines/category_1.
63
2023.
Available
from:
1.
Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution
in anal cancer and anal intraepithelial lesions. Int J Cancer. 2009;124(10):2375-83.
2.
Deshmukh AA, Suk R, Shiels MS, Sonawane K, Nyitray AG, Liu Y, et al. Recent Trends
in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001-2015.
J Natl Cancer Inst. 2020;112(8):829-38.
3.
Palefsky JM, Giuliano AR, Goldstone S, Moreira ED, Jr., Aranda C, Jessen H, et al.
HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med.
2011;365(17):1576-85.
4.
Bruyere D, Monnien F, Colpart P, Roncarati P, Vuitton L, Hendrick E, et al. Treatment
algorithm and prognostic factors for patients with stage I-III carcinoma of the anal canal: a 20-year
multicenter study. Mod Pathol. 2021;34(1):116-30.
5.
McBride AA, Warburton A. The role of integration in oncogenic progression of HPV-
associated cancers. PLoS Pathog. 2017;13(4):e1006211.
6.
Salati SA, Al Kadi A. Anal cancer - a review. Int J Health Sci (Qassim). 2012;6(2):206-
30.
7.
Gervaz P, Hirschel B, Morel P. Molecular biology of squamous cell carcinoma of the anus.
Br J Surg. 2006;93(5):531-8.
8.
D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control
study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944-56.
9.
Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human
papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):2435.
10.
Hama T, Tokumaru Y, Fujii M, Yane K, Okami K, Kato K, et al. Prevalence of human
papillomavirus in oropharyngeal cancer: a multicenter study in Japan. Oncology. 2014;87(3):17382.
11.
Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for
a causal association between human papillomavirus and a subset of head and neck cancers. J Natl
Cancer Inst. 2000;92(9):709-20.
12.
Nguyen NP, Chi A, Nguyen LM, Ly BH, Karlsson U, Vinh-Hung V. Human
papillomavirus-associated oropharyngeal cancer: a new clinical entity. Qjm. 2010;103(4):229-36.
13.
Klussmann JP, Mooren JJ, Lehnen M, Claessen SM, Stenner M, Huebbers CU, et al.
Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic
implications. Clin Cancer Res. 2009;15(5):1779-86.
14.
Network
NCC.
NCCN
Guidelines
https://www.nccn.org/guidelines/category_1.
63
2023.
Available
from: